Demonstrating the Value of Laboratory Medicine through Population Health

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Project Santa Fe Foundation Faculty
    Biography

      During her career, Ms. Swanson has worked with a wide range of professionals in health care and business to develop and facilitate new programs.  Ms. Swanson has been recognized as a leader and mentor, served on several Board of Director positions and as an elected officer for state and national groups. Ms. Swanson practiced pharmacy in a variety of environments including inpatient, outpatient, clinical, managed care, and research.  In addition to her practice experience, she has overseen local and national programs for quality management, performance improvement and measurement systems.  More recently, Ms. Swanson worked as the Director of Clinical Solutions at TriCore Reference Laboratories where she led the development and implementation of state-wide population health initiatives for high prevalence conditions in New Mexico using laboratory data. Currently she is a member of the Project Santa Fe Foundation Faculty working with multi-site groups to demonstrate the value of laboratory insights to improve patient care and reduce total costs.


    Abstract

    Clinical Laboratories have the opportunity to support value based health care by aligning with organizational strategies that focus on population health and creating meaningful insights using real time longitudinal laboratory data.  To provide diagnostic insights, laboratorians must move from providing results for a single patient, to a population focus for groups of patients.  The presentation will include examples on how data can be positioned to support the screening, diagnosis, monitoring and intervention management for groups of patients with chronic and high cost health conditions. The use of Clinical Lab 2.0 concepts to frame the development of these population based initiatives will be discussed.   Key components that will be highlighted are leadership, selecting population based initiatives, and items to consider when building an evidence base. Examples discussed will include risk stratification and identification of gaps in care. Partnerships, both inside and outside the laboratory, essential for these efforts will be described.   Partner relationships with data analytics will be covered as one of the most important components to successfully deliver insights to a variety of stakeholders including clinical providers, healthcare administrators and health plans. Measuring the success of laboratory driven population health initiatives can be challenging and complex.  This presentation will describe several measures that can be used to demonstrate value both clinically and financially.  Barriers to population health initiatives will also be included in the presentation.

    Learning Objectives:

    1. At the end of the presentation audience members will be able to identify several Clinical Lab 2.0 components that should be included when developing population health initiatives from laboratory data

    2. At the end of the presentation audience members will be able to explain the role of key partnerships both inside and outside the laboratory

    3. At the end of the presentation audience members will be able to describe at least 2 examples of how clinical laboratory data can be used to provide meaningful insights supporting population health.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    Loading Comments...
    Show Resources